As I understand it,QRS's licencing agreement with BTG expires in 2009.Too close for my liking.Also the competitive threat posed by Varian Medical Systems needs to be assessed.(VAR,NYSE)Comments appreciated.
Market Close: The US Fed rate is one thing – but are FDI outflows bringing down a boring ASX in favour of Wall Street?
